Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
Ethyl 3-(4-chlorophenyl)propanoate functions as a crucial drug intermediate in the synthesis of various active pharmaceutical compounds. This reagent facilitates the production of biologically active molecules, aiding in the development of therapeutic agents. Its chemical structure and reactivity make it valuable in medicinal chemistry research and substance synthesis. -
Drug Intermediate
tert-Butyl (2-(2-chloro-4-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)ureido)phenethoxy)ethyl)(methyl)carbamate serves as a critical intermediate in the synthesis of diverse bioactive compounds. This versatile reagent is utilized in the development of pharmaceutical agents with potential therapeutic applications. Its unique structure allows for the exploration of new chemical entities in drug discovery and optimization processes. -
Drug Intermediate
Ho-peg2-(ch2)6-Cl is a versatile drug intermediate characterized by its 6-chlorohexyl ether structure. It plays a crucial role in the synthesis of a variety of biologically active compounds, making it an essential reagent in pharmaceutical research and development. The compound's unique functional groups enable the exploration of new therapeutic agents and aid in the advancement of drug discovery projects. -
Drug Intermediate
7-(tert-Butyl) 2-methyl 3-bromo-7-azabicyclo[2.2.1]hepta-2,5-diene-2,7-dicarboxylate functions as a key drug intermediate in the synthesis of diverse active pharmaceutical compounds. This targeted molecule features unique bicyclic architecture, facilitating its application in the development of complex chemical entities. Key biological activity can support research in medicinal chemistry and drug discovery processes. -
Drug Intermediate
4-Bromo-1-methyl-1H-pyrrole-2-carbonitrile serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This compound is instrumental in the development of pharmaceuticals due to its structural features, which enable the formation of various substituted pyrrole derivatives. It is widely utilized in medicinal chemistry for conducting research on drug discovery and optimization. -
Drug Intermediate
Ethyl (2R)-2-acetoxy-3-(2-hydroxyphenyl)propanoate serves as a key drug intermediate in the synthesis of various biologically active compounds. Its structural properties facilitate the creation of targeted pharmaceutical entities, making it essential for medicinal chemistry research. This compound is significant for those engaged in the development of novel therapeutics. -
Drug Impurity
Apixaban impurity 13 is a chemical impurity associated with the anticoagulant drug Apixaban. This compound is critical for analytical and quality control studies in pharmaceutical research, particularly in assessing the purity of Apixaban formulations. The presence of such impurities can affect the pharmacological profile and safety of the final product, making it essential for ensuring compliance with regulatory standards in drug development. -
Drug Intermediate
N-(Benzotriazol-1-ylmethyl)-N-benzyl-1-phenylmethanamine functions as a key drug intermediate in organic synthesis. This compound plays a crucial role in the preparation of various bioactive molecules, facilitating the development of new pharmaceutical agents. Its utility in drug discovery makes it an important reagent for researchers focused on synthesizing innovative therapeutic compounds. -
Drug Intermediate
3-Methyl-5-nitropyridine is a versatile drug intermediate primarily utilized in the synthesis of various biologically active compounds. This pyridine derivative exhibits key chemical reactivity that facilitates the development of pharmaceutical agents. It is valuable in medicinal chemistry and organic synthesis applications, contributing to the advancement of new therapeutic entities. -
Drug Intermediate
tert-Butyl (4-(prop-2-yn-1-yloxy)benzyl)carbamate is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound serves as an essential building block in medicinal chemistry, enabling the development of novel pharmaceuticals. Its unique structure supports the formation of diverse chemical entities, facilitating research in drug discovery and optimization. -
Drug Intermediate
6-(Hydroxymethyl)-4-phenylchroman-2-ol serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This reagent is integral in developing pharmaceuticals due to its role in modifying and enhancing therapeutic properties. Its structural features facilitate complex chemical transformations, making it essential for researchers in medicinal chemistry and drug development. -
Drug Intermediate
2-(Aminomethyl)-N1,N1-dimethylpropane-1,3-diamine trihydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the formation of compounds with potential therapeutic applications. This reagent is essential for researchers focusing on the development of new pharmaceuticals and chemical entities. -
Drug Intermediate
5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester dihydrochloride hydrate is a versatile drug intermediate primarily utilized in the synthesis of various bioactive compounds. This compound features a benzofuran moiety, which enhances its potential in medicinal chemistry applications. It serves as an essential building block for the development of novel pharmaceuticals, particularly in the fields of neuropharmacology and analgesics. -
Drug Impurity
N,N-Dibenzylacetamide is a drug impurity commonly encountered in pharmaceutical formulations. Its presence can influence the pharmacokinetics and efficacy of active pharmaceutical ingredients. This compound is of particular interest for analytical research focused on drug quality assessment and regulatory compliance. Understanding and analyzing impurities such as N,N-Dibenzylacetamide is crucial for ensuring the safety and effectiveness of drug products. -
Drug Intermediate
(R)-6-(Propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride serves as a valuable drug intermediate in the synthesis of diverse pharmacologically active compounds. Its structure facilitates modifications for the development of therapeutics, making it a useful tool in medicinal chemistry research and drug discovery processes. -
Drug Intermediate
(2S,4R)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid serves as a critical drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features facilitate the development of therapeutics with enhanced efficacy and selectivity. This reagent is instrumental for researchers exploring novel drug formulations and chemical pathways in medicinal chemistry. -
Drug Intermediate
2-Methylbenzo[d]oxazol-6-ol serves as a crucial drug intermediate in the synthesis of a variety of bioactive compounds. Its structural properties facilitate the development of pharmaceuticals, allowing for efficient alterations in chemical frameworks. This compound is essential for researchers focused on drug design and synthesis in medicinal chemistry. -
Drug Intermediate
(S)-2-allylpyrrolidine-2-carboxylic acid hydrochloride acts as a key drug intermediate in the synthesis of various bioactive compounds. This compound plays a crucial role in pharmaceutical research and development, facilitating the creation of novel therapeutics. Its utility in organic synthesis makes it a valuable reagent in the production of complex molecular structures. -
Drug Intermediate
2-Acetoxy-2-methylpropanoic acid is a versatile drug intermediate utilized in the synthesis of a range of bioactive compounds. Its structural functionality enables the creation of various derivatives, making it an essential reagent for pharmaceutical research and development. This compound is particularly relevant in the study and design of novel therapeutic agents. -
Drug Intermediate
5-Amino-1,3-dimethyl-6-(3-propoxyphenoxy)-1H-benzo[d]imidazol-2(3H)-one serves as a versatile drug intermediate in the synthesis of diverse biologically active compounds. Its unique structure allows for modifications that can enhance drug efficacy and specificity. This reagent is valuable in medicinal chemistry and drug development research applications. -
Drug Intermediate
Nicotinimidamide hydrochloride serves as a critical drug intermediate in the synthesis of various active pharmaceutical compounds. It is employed in the development of therapeutic agents, facilitating the production of innovative treatments across different medicinal chemistry applications. Its structural attributes make it valuable for optimizing the pharmacological properties of resultant compounds. -
Drug Intermediate
5-Methoxyresorcinol is a drug intermediate that mimics the chemical structure of the resorcinol-type A ring found in flavonoids, particularly catechins. This compound demonstrates low reactivity with tocopherol and exhibits minimal inhibitory effects on cholesteryl ester transfer protein (CETP). Its unique properties make it a valuable tool for research applications involving flavonoid-related biochemical studies and drug development. -
Drug Intermediate
Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate serves as a critical drug intermediate in the synthesis of diverse pharmacologically active compounds. This reagent is essential for developing new therapeutic agents, facilitating research in medicinal chemistry and drug discovery. Its structural characteristics make it suitable for various modifications to yield targeted bioactive molecules. -
Drug Intermediate
(3-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)methanol is a notable drug intermediate utilized in the synthesis of diverse bioactive compounds. Its structural framework supports the development of therapeutic agents, highlighting its importance in medicinal chemistry research. This reagent facilitates the creation of complex molecules, enabling advancements in the study and treatment of various diseases. -
Drug Intermediate
3-(1H-Benzimidazol-1-yl)propan-1-amine acts as a vital drug intermediate in the synthesis of multiple bioactive compounds. This molecule facilitates the development of pharmaceuticals by providing a structural framework for various therapeutic agents. Its applications extend across biochemical research, particularly in the fields of medicinal chemistry and drug discovery. -
Drug Intermediate
4-Amino-6-hydroxy-2-mercaptopyrimidine mono hydrate serves as a key drug intermediate in the synthesis of various active pharmaceutical compounds. This molecule plays a critical role in the development of therapeutics by contributing to the formation of biologically relevant heterocycles. Its unique chemical structure supports research applications in medicinal chemistry and drug discovery. -
Biochemical Reagent
Tributylammonium hemipyrophosphate is a biochemical reagent that acts as an important intermediate in the synthesis of nucleoside triphosphates. Its utility in facilitating the phosphorylation of nucleotides makes it valuable for various biochemical assays and research applications involving nucleic acid metabolism and signaling pathways. This compound supports investigations into energy transfer and enzyme-catalyzed processes in cellular systems. -
Drug Intermediate
Ethyl 1-(2-bromoacetyl)cyclopropanecarboxylate is a versatile drug intermediate that facilitates the synthesis of diverse active pharmaceutical compounds. It plays a crucial role in organic chemistry, particularly in the development of novel therapeutics. This reagent can be utilized effectively in various research applications aimed at drug discovery and synthesis. -
Drug Intermediate
4-Amino-3-methoxybenzoic acid serves as an essential drug intermediate in the synthesis of benzothiazole derivatives, which are noted for their anti-breast cancer properties. This compound is valuable in medicinal chemistry for developing potential therapeutic agents targeting breast cancer. Its functional groups facilitate further chemical modifications, enhancing its suitability for various research applications in cancer treatment. -
Drug Intermediate
4-Bromo-3-(trifluoromethyl)aniline is a versatile drug intermediate utilized in the synthesis of AUY954, a selective S1P1 receptor agonist. This compound is significant in the development of therapeutics targeting sphingosine-1-phosphate receptors, which are implicated in various physiological processes and disease states. It serves as a crucial building block for researchers exploring novel treatments in immunology and neurobiology. -
Drug Intermediate
3,5-Dimethylisoxazole-4-boronic acid pinacol ester is a versatile drug intermediate primarily used in the synthesis of bromodomain inhibitors. Its unique chemical structure facilitates the development of small molecules targeting bromodomains, which are critical in regulating gene expression and various cellular processes. This compound is essential in medicinal chemistry for the design of novel therapeutics aimed at cancer and other diseases associated with aberrant bromodomain activity. -
Drug Intermediate
(2-Methoxypyrimidin-5-yl)boronic acid is a versatile drug intermediate primarily utilized in Suzuki-Miyaura coupling reactions. This compound facilitates the synthesis of isoquinoline ketone derivatives, which exhibit notable anti-tumor activity. Its application is valuable in the development of novel therapeutic agents in cancer research. -
Drug Intermediate
2-(Pyridin-2-yl)acetic acid hydrochloride is a heterocyclic aromatic carboxylic acid that serves as a valuable drug intermediate in organic synthesis. Its unique structure allows it to participate in the formation of metal complexes, expanding its utility in various chemical research applications. This compound is a versatile tool for researchers investigating synthetic methodologies and compounds derived from pyridine. -
Drug Intermediate
3-Amino-5-methylpyrazole is a pyrazole heterocyclic compound primarily utilized as a drug intermediate. This compound serves as a crucial building block for the synthesis of various pyrazolylamide derivatives, which may exhibit significant biological activity in pharmaceutical research. Its versatility in organic synthesis makes it an essential reagent for developing novel therapeutics. -
Drug Impurity
Leflunomide impurity 7 is a known impurity associated with Leflunomide, an immunosuppressive agent. This compound is primarily utilized in research for quality control and characterization of Leflunomide formulations. It provides insights into the synthesis process and potential impacts on drug efficacy and safety profiles during pharmaceutical development. -
Drug Intermediate
Acetylpyrazine is a key drug intermediate notable for its role in the synthesis of various polycyclic compounds, which serve as valuable structures in pharmaceuticals and fragrances. Additionally, Acetylpyrazine contributes to the formation of folates, essential vitamin B compounds, thereby playing a significant role in biological systems. Its diverse applications in chemical research enhance its utility in the development of therapeutic agents and other chemical products. -
Drug Intermediate
(R)-Phenyl (5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)carbamate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. With its unique structural features, it facilitates the development of targeted therapies in medicinal chemistry research. This compound is of particular interest for studies aiming to enhance pharmaceutical efficacy and optimize lead compounds. -
Drug Impurity
Tolterodine impurity 1 is a chemical impurity associated with Tolterodine, a pharmaceutical agent primarily used for the management of overactive bladder. This impurity may be utilized in research applications focused on drug formulation, stability analysis, and quality control to ensure the purity and safety of pharmaceutical products. Characterization of this impurity can aid in the understanding of Tolterodine metabolism and its potential effects on pharmacokinetics. -
Drug Impurity
Ketoprofen impurity 2 is a chemical impurity associated with Ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID). This impurity can be utilized in the study of drug purity and stability, aiding in the assessment of pharmaceutical quality control. Its characterization is essential for compliance with regulatory standards in pharmaceutical development and manufacturing. -
Drug Intermediate
4-(Trifluoromethoxy)benzenesulfinate sodium is a versatile drug intermediate used in the synthesis of a range of active pharmaceutical compounds. Its sulfinyl group contributes to the modulation of biological activity, making it a valuable building block in medicinal chemistry. Researchers can utilize this compound for developing new therapeutic agents and exploring structure-activity relationships. -
Drug Intermediate
1-([1,1'-Biphenyl]-2-yl)piperazine hydrochloride serves as a versatile drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structure facilitates the development of compounds with potential therapeutic applications in various areas of medicinal chemistry. This reagent is essential for researchers engaged in the design and synthesis of novel bioactive molecules. -
Drug Impurity
Metformin impurity 12, also known as N2,N2-Dimethylmelamine, is a recognized impurity associated with the synthesis of Metformin. This compound is of significant interest in the study of pharmaceutical quality and safety, aiding in the assessment of drug formulations. It serves as a reference standard for analytical techniques, providing critical data for ensuring the purity and efficacy of Metformin-based medications. -
Drug Intermediate
1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique fluorinated structure enables the development of compounds with distinct biological profiles. This reagent is particularly valuable in medicinal chemistry and can aid in research aimed at generating novel therapeutics. -
Drug Intermediate
2-(4-Hydroxy-3-oxobutyl)isoindoline-1,3-dione serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique structural characteristics facilitate the development of compounds with significant biological activity, making it valuable in medicinal chemistry and pharmaceutical research. This compound's versatility supports a range of applications in the study of drug formulation and development. -
Drug Intermediate
2-(Pyridin-4-yl)benzo[d]oxazol-5-amine is a critical drug intermediate utilized in the synthesis of diverse bioactive compounds. This compound plays a significant role in medicinal chemistry, facilitating the development of new therapeutic agents. Its structural features position it as a valuable building block in research focused on innovative pharmaceutical formulations. -
Drug Impurity
Sacubitrilat impurity 32 is an identified impurity associated with the therapeutic agent Sacubitrilat. Its presence in pharmaceutical formulations may have implications for drug quality, safety, and efficacy. This reagent is utilized in the analysis and characterization of Sacubitrilat to ensure compliance with regulatory standards and to support research in drug metabolism and pharmacokinetics. -
Drug Intermediate
7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione serves as a crucial drug intermediate in the synthesis of diverse pharmacologically active compounds. This compound plays a significant role in organic synthesis pathways, facilitating the development of novel therapeutics. Its unique structural properties make it valuable for researchers exploring new drug candidates. -
Drug Impurity
Edoxaban impurity 11 is a known impurity associated with the anticoagulant Edoxaban. This compound is utilized in analytical chemistry and pharmacological research to assess the purity and quality of Edoxaban formulations. Its presence can impact the safety and efficacy of drug products, making it vital for regulatory compliance and stability studies. -
Drug Intermediate
2-Benzyl-2,5-diazaspiro[3.4]octane dihydrochloride is primarily utilized as a drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique spirocyclic structure contributes to its potential in medicinal chemistry, facilitating the development of novel therapeutic agents. This compound serves as a crucial building block in the creation of various biologically active molecules, making it valuable for research in drug discovery and development. -
Drug Intermediate
2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one serves as a vital drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features enable facilitation in the preparation of complex molecules, enhancing drug development efforts. This reagent is instrumental in organic synthesis and medicinal chemistry applications, contributing to innovations in therapeutic agents.
